October 09, 2012 13:45 ET

U.S. Over-the-Counter Diagnostic Testing Market to Catapult to $10.19 Billion by 2018

NEW YORK, NY--(Marketwire - Oct 9, 2012) - cites in its newly published "Over-the-Counter Diagnostic Products World Markets" report that the U.S. over-the-counter diagnostic testing products market will catapult to $10.19 billion by 2018. For more information, visit:

The over-the-counter diagnostic testing products market can be categorized into two main modalities: home testing (where products are purchased at pharmacies and drug stores) and decentralized testing in non-institutional settings (insurance companies and law enforcement agencies). Within these modalities, there are many types of over-the-counter diagnostic testing products, including tests for glucose monitoring, pregnancy, drugs of abuse screening, infectious disease, hepatitis, HIV, coagulation and fertility. A worldwide growth rate of approximately 10.4% is projected for over-the-counter diagnostic testing products between 2011 and 2018.

The "Over-the-Counter Diagnostic Products World Markets" report covers:

  • In-Home HIV Testing
  • Coagulation Testing
  • Urine Dipstick Testing
  • Fertility Testing
  • In-Home DNA Analysis
  • Biowarfare Detection
  • Home Patient Monitoring Devices
  • Home Patient Alert Systems
  • Home Genetic Testing Kits
  • Home Paternity Testing
  • Health Hazards Detection
  • Colorectal Cancer (Occult Blood) Testing
  • Alzheimer's Disease Home Screening Test
  • Tobacco Testing
  • Cholesterol Testing
  • Immunoassay Technology
  • Biosensor Technology
  • Home Telemedicine Devices
  • Insulin Pumps

The "Over-the-Counter Diagnostic Products World Markets" report examines companies manufacturing over-the-counter diagnostic testing products equipment and supplies in the world. Companies covered include: A Menarini, Abbott, ACON, AgaMatrix, Alere, American Bio Medica, AmeriSourceBergen, Ani Biotech, ARKRAY, Bayer, Becton Dickinson, Biomerica, Calypte, Cardinal, HemoCue, Home Access, Insulet, International Technidyne Nexus, Johnson & Johnson, LifeScan, NOVA, OraQuick, Orasure, Princeton BioMeditech, Quidel, Roche, Saliva and Trinity Biotech.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit:

About is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Contact Information